A Study of Single-dose MY008211A in Healthy Adults

Clinical trial NCT05642585 · COMPLETED

Trial details

NCT number: NCT05642585
Sponsor: Wuhan Createrna Science and Technology Co., Ltd
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Paroxysmal Nocturnal Hemoglobinuria

Start date: 2022-05-27
Primary completion: 2023-06-04
Enrollment: 63

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.